Acta Ophthalmologica Polonica
twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Review article

Current insights into the diagnosis and management of melanocytic choroidal tumors: a short review

Emilia Zwolińska
1
,
Lazaros Konstantinidis
2
,
Iwona Rospond-Kubiak
1

  1. Department of Ophthalmology, Poznan University of Medical Sciences, Poland
  2. Jules Gonin University Eye Hospital, Lausanne, Switzerland
KLINIKA OCZNA 2025, 127, 3:
DOI: https://doi.org/10.5114/ko.2025.153643
Online publish date: 2025/08/22
Article file
- KO-00503_EN.pdf  [1.94 MB]
Get citation
 
PlumX metrics:
 
1. Kaliki S, Shields CL. Uveal melanoma: relatively rare but deadly cancer. Eye 2017; 31: 241-257.
2. Singh AD, Kalyani P, Topham A. Estimating the Risk of Malignant Transformation of a Choroidal Nevus. Ophthalmology 2005; 112: 1784-1789.
3. Papastefanou VP, Nogueira V, Hay G, et al. Choroidal naevi complicated by choroidal neovascular membrane and outer retinal tubulation. Br J Ophthalmol 2013; 97: 1014-1019.
4. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992; 110: 245-250.
5. Smidt‐Nielsen I, Bagger M, Heegaard S, et al. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70‐year nationwide cohort. Acta Ophthalmol 2021; 99: e1474-e1482.
6. Ng CH. Prevalence and Characteristics of Choroidal Nevi in an Asian vs White Population. Arch Ophthalmol 2009; 127: 314.
7. Greenstein MB, Myers CE, Meuer SM, et al. Prevalence and Characteristics of Choroidal Nevi: The Multi-Ethnic Study of Atherosclerosis. Ophthalmology 2011; 118: 2468-2473.
8. Jonas JB, You QS, Xu L, Wang YX. Choroidal Nevi in Adult Chinese. Ophthalmology 2008; 115: 1102-1102.e1.
9. Sumich P. Choroidal Nevi in a White Population: The Blue Mountains Eye Study. Arch Ophthalmol 1998; 116: 645.
10. Nangia V, Jonas JB, Agarwal S, Khare A, Lambat S, Panda-Jonas S. Choroidal nevi in adult Indians: The Central India Eye and Medical Study. Br J Ophthalmol 2012; 96: 1443.1-1444.
11. Qiu M, Shields CL. Choroidal Nevus in the United States Adult Population. Ophthalmology 2015; 122: 2071-2083.
12. Virgili G, Gatta G, Ciccolallo L, et al. Incidence of Uveal Melanoma in Europe. Ophthalmology 2007; 114: 2309-2315.e2.
13. Raval V, Bellerive C, Singh AD, Gopinath B, Liew G, Mitchell P. Choroidal nevi in children: prevalence, age of onset, and progression. J AAPOS. 2021 Aug;25(4):225.e1-225.e6.
14. Shields CL, Kaliki S, Arepalli S, et al. Uveal melanoma in children and teenagers. Saudi J Ophthalmol 2013; 27: 197-201.
15. Andreoli MT, Mieler WF, Leiderman YI. Epidemiological trends in uveal melanoma. Br J Ophthalmol 2015; 99: 1550-1553.
16. Strickland D, Lee JAH. Melanomas of eye: stability of rates. Am J Epidemiol 1981; 113: 700-702.
17. Stang A, Parkin DM, Ferlay J, Jöckel KH. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification: International Uveal Melanoma Incidence Trends. Int J Cancer 2005; 114: 114-123.
18. Naumann G, Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea. I. Histopathologic characteristics of nevi of the choroid and ciliary body. Arch Ophthalmol 1966; 76: 784-796.
19. Yanoff M, Zimmerman LE. Histogenesis of malignant melanomas of the uvea.II. Relationship of uveal nevi to malignant melanomas. Cancer 1967; 20: 493-507.
20. Rietschel P, Panageas KS, Hanlon C, et al. Variates of Survival in Metastatic Uveal Melanoma. J Clin Oncol 2005; 23: 8076-8080.
21. Carvajal RD, Schwartz GK, Tezel T, et al. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol 2017; 101: 38-44.
22. Stålhammar G, Gill VT. The long-term prognosis of patients with untreated primary uveal melanoma: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2022; 172: 103652.
23. Jouhi S, Jager MJ, De Geus SJR, et al. The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group. Am J Ophthalmol 2019; 202: 100-108.
24. Shields CL, Dalvin LA, Ancona-Lezama D, et al. Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases. Retina 2019; 39: 1840-1851.
25. Shields CL, Lally SE, Dalvin LA, et al. White paper on ophthalmic imaging for choroidal nevus identification and transformation into Melanoma 2021; 10: 1-10.
26. Kubicka-Trzaska A, Starzycka M, Romanowska-Dixon B. Indocyanine Green Angiography in the Diagnosis of Small Choroidal Tumours. Ophthalmologica 2002; 216: 316-319.
27. Yannuzzi LA. Indocyanine Green Angiography: A Perspective on Use in the Clinical Setting. Am J Ophthalmol 2011; 151: 745-751.e1.
28. Shields CL, Shields JA, Kiratli H, et al. Risk Factors for Growth and Metastasis of Small Choroidal Melanocytic Lesions. Ophthalmology 1995; 102: 1351-1361.
29. Shields CL, Furuta M, Berman EL, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol 2009; 127: 981-987.
30. Factors Predictive of Growth and Treatment of Small Choroidal Melanoma: COMS Report No. 5. Arch Ophthalmol 1997; 115: 1537.
31. Dalvin LA, Shields CL, Ancona-Lezama DA, et al. Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma. Br J Ophthalmol 2019; 103: 1441-1447.
32. Shields CL, Dalvin LA, Yu MD, et al. Choroidal nevus transformation into melanoma per millimeter increment in thickness using multimodal imaging in 2355 cases: The 2019 Wendell L. Hughes Lecture. Retina 2019; 39: 1852-1860.
33. Roelofs KA, O’Day R, Harby LA, et al. The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe? Cancers (Basel) 2020; 12: 1311.
34. Al Harby L, Sagoo MS, O’Day R, et al. Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic. Ocul Oncol Pathol 2021; 7: 294-302.
35. Damato BE. Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours? Eye 2023; 37: 830-836.
36. Ching J, AlHarby L, Sagoo MS, Damato B. Is Tumour Thickness Measurement Required for MOLES Scoring of Melanocytic Choroidal Tumours? Ocul Oncol Pathol 2023; 9: 40-47.
37. Barbagallo C, Stella M, Broggi G, et al. Genetics and RNA Regulation of Uveal Melanoma. Cancers 2023; 15: 775.
38. Afshar AR, Damato BE, Stewart JM, et al. Next-Generation Sequencing of Uveal Melanoma for Detection of Genetic Alterations Predicting Metastasis. Transl Vis Sci Technol. 2019; 8: 18.
39. Robertson AG, Shih J, Yau C, et al. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell 2017; 32: 204-220.e15.
40. Scholes AGM, Damato BE, Nunn J, et al. Monosomy 3 in Uveal Melanoma: Correlation with Clinical and Histologic Predictors of Survival. Investig Opthalmology Vis Sci 2003; 44: 1008.
41. Louie BH, Kurzrock R. BAP1: Not just a BRCA1-associated protein. Cancer Treat Rev 2020; 90: 102091.
42. Pilarski R, Byrne L, Carlo MI, Hanson H, Cebulla C, Abdel-Rahman M. BAP1 Tumor Predisposition Syndrome. 2016 Oct 13 [updated 2024 Dec 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
43. Bornfeld N, Prescher G, Becher R, et al. Prognostic implications of monosomy 3 in uveal melanoma. The Lancet 1996; 347: 1222- 1225.
44. White VA, McNeil BK, Horsman DE. Acquired Homozygosity (Isodisomy) of Chromosome 3 in Uveal Melanoma. Cancer Genet Cytogenet 1998; 102: 40-45.
45. Le Guin CHD, Metz KA, Lehmann N, et al. Chromosome 3 is a valid marker for prognostic testing of biopsy material from uveal melanoma later treated by brachytherapy. Biomarkers 2019; 24: 134-140.
46. Martin M, Maßhöfer L, Temming P, et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 2013; 45: 933-936.
47. Silva-Rodríguez P, Fernández-Díaz D, Bande M, et al. GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma. Cancers 2022; 14: 3066.
48. Onken MD, Worley LA, Long MD, et al. Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma. Investig Opthalmology Vis Sci 2008; 49: 5230.
49. van den Bosch T, Kilic E, Paridaens D, de Klein A. Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind? Dermatol Res Pract 2010; 2010: 1-13.
50. Vader MJC, Madigan MC, Versluis M, et al. GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi. Br J Cancer 2017; 117: 884-887.
51. Staby KM, Gravdal K, Mørk SJ, et al. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma. Acta Ophthalmol (Copenh) 2018; 96: 31-38.
52. Harbour JW, Onken MD, Roberson EDO, et al. Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas. Science 2010; 330: 1410-1413.
53. Koopmans AE, Verdijk RM, Brouwer RWW, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 2014; 27: 1321-1330.
54. Uner OE, See TRO, Szalai E, et al. Estimation of the timing of BAP1 mutation in uveal melanoma progression. Sci Rep 2021; 11: 8923.
55. Golas MM, Sander B, Will CL, et al. Molecular Architecture of the Multiprotein Splicing Factor SF3b. Science 2003; 300: 980-984.
56. Leeksma AC, Derks IAM, Kasem MH, et al. The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer. Front Oncol 2021; 10: 609409.
57. Furney SJ, Pedersen M, Gentien D, et al. SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma. Cancer Discov 2013; 3: 1122-1129.
58. Harbour JW, Roberson EDO, Anbunathan H, et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 2013; 45: 133-135.
59. Thornton S, Coupland S, Olohan L, et al. Targeted Next-Generation Sequencing of 117 Routine Clinical Samples Provides Further Insights into the Molecular Landscape of Uveal Melanoma. Cancers 2020; 12: 1039.
60. Yavuzyigitoglu S, Koopmans AE, Verdijk RM, et al. Uveal Melanomas with SF3B1 Mutations. Ophthalmology 2016; 123: 1118–1128.
61. Field MG, Decatur CL, Kurtenbach S, et al. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma. Clin Cancer Res 2016; 22: 1234-1242.
62. Chaudhuri J, Si K, Maitra U. Function of Eukaryotic Translation Initiation Factor 1A (eIF1A) (Formerly Called eIF-4C) in Initiation of Protein Synthesis. J Biol Chem 1997; 272: 7883-7891.
63. Ewens KG, Kanetsky PA, Richards-Yutz J, et al. Chromosome 3 Status Combined With BAP1 and EIF1AX Mutation Profiles Are Associated With Metastasis in Uveal Melanoma. Investig Opthalmology Vis Sci 2014; 55: 5160.
64. Küsters-Vandevelde HV, Creytens D, van Engen-van Grunsven AC, et al. SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas. Acta Neuropathol Commun 2016; 4: 5.
65. Hunter SM, Anglesio MS, Ryland GL, et al.; Australian Ovarian Cancer Study Group. Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes. Oncotarget 2015; 6: 37663-37677.
66. Chien JL, Sioufi K, Surakiatchanukul T, et al. Choroidal nevus: a review of prevalence, features, genetics, risks, and outcomes. Curr Opin Ophthalmol 2017; 28: 228-237.
67. Pandiani C, Béranger GE, Leclerc J, et al. Focus on cutaneous and uveal melanoma specificities. Genes Dev 2017; 31: 724-743.
68. Brănișteanu DE, Porumb-Andrese E, Stărică A, et al. Differences and Similarities in Epidemiology and Risk Factors for Cutaneous and Uveal Melanoma. Medicina (Mex) 2023; 59: 943.
69. Kvanta A, Seregard S, Kopp ED, et al. Choroidal Biopsies for Intraocular Tumors of Indeterminate Origin. Am J Ophthalmol 2005; 140: 1002-1006.
70. Angi M, Kalirai H, Taktak A, et al. Prognostic biopsy of choroidal melanoma: an optimised surgical and laboratory approach. Br J Ophthalmol 2017; 101: 1143-1146.
71. McCannel TA. Fine-needle aspiration biopsy in the management of choroidal melanoma. Curr Opin Ophthalmol 2013; 24: 262-266.
72. Midena E, Bonaldi L, Parrozzani R, et al. In vivo Detection of Monosomy 3 in Eyes with Medium-Sized Uveal Melanoma using Transscleral Fine Needle Aspiration Biopsy. Eur J Ophthalmol 2006; 16: 422-425.
73. Singh AD, Medina CA, Singh N, et al. Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications. Br J Ophthalmol 2016; 100: 456-462.
74. Hussain RN, Damato B, Heimann H. Choroidal biopsies; a review and optimised approach. Eye 2023; 37: 900-906.
75. Sen J, Groenewald C, Hiscott PS, et al. Transretinal Choroidal Tumor Biopsy with a 25-Gauge Vitrector. Ophthalmology 2006; 113: 1028-1031.
76. Kim RS, Chevez-Barrios P, Bretana ME, et al. Histopathologic Analysis of Transvitreal Fine Needle Aspiration Biopsy Needle Tracts for Uveal Melanoma. Am J Ophthalmol 2017; 174: 9-16.
77. Eide N, Walaas L. Fine‐needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review. Acta Ophthalmol (Copenh) 2009; 87: 588-601.
78. Shields CL, Materin MA, Teixeira L, et al. Small Choroidal Melanoma with Chromosome 3 Monosomy on Fine-Needle Aspiration Biopsy. Ophthalmology 2007; 114: 1919-1924.
79. Schefler AC, Gologorsky D, Marr BP, et al. Extraocular Extension of Uveal Melanoma After Fine-Needle Aspiration, Vitrectomy, and Open Biopsy. JAMA Ophthalmol 2013; 131: 1220.
80. Bagger M, Smidt-Nielsen I, Andersen MK, et al. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma. Ophthalmology 2018; 125: 1969-1976.
81. Augsburger JJ, Shields JA, Folberg R, et al. Fine Needle Aspiration Biopsy in the Diagnosis of Intraocular Cancer. Ophthalmology 1985; 92: 39-49.
82. Hussain RN, Damato B, Heimann H. Choroidal biopsies; a review and optimised approach. Eye 2023; 37: 900-906.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.